Nunn Jason Raleigh

CIK 00014443198 companiesGENEVA

SEC Profile

Transactions

Companies

Filings

CIK

0001444319

Recent Transactions

50 trades

Disposition to Issuer
Addex Therapeutics Ltd.$ADXN
Stock-option (Right to Buy)
2026-09-02−50,000→ 0 total
Award
Addex Therapeutics Ltd.$ADXN
Stock-option (Right to Buy)
2026-09-02+50,000→ 50,000 total
Disposition to Issuer
Addex Therapeutics Ltd.$ADXN
Common Stock
2026-09-02−219,561→ 0 total
Award
Addex Therapeutics Ltd.$ADXN
Common Stock
2026-09-02+219,561→ 219,561 total
Award
Zenas BioPharma, Inc.$ZBIO
Stock Option (Right to Buy)
2026-06-15+18,500→ 18,500 total
Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2025-10-09$19.00/sh+63,158→ 1,173,395 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−15,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−30,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−60,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−4,650→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−2,325→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Common Stock
2025-06-25−62,500→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−4,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−9,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−30,000→ 0 total
Award
Zenas BioPharma, Inc.$ZBIO
Stock Option (Right to Buy)
2025-06-10+18,500→ 18,500 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-04-30+62,500→ 62,500 total
Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16$17.00/sh+441,176→ 1,110,237 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+1,505,388→ 1,505,388 total
Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16$17.00/sh+441,176→ 1,946,564 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+669,061→ 669,061 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series C Convertible Preferred Stock
2024-09-16−13,071,439→ 0 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series C Convertible Preferred Stock
2024-09-16−5,809,528→ 0 total
Award
Zenas BioPharma, Inc.$ZBIO
Stock Option (Right to Buy)
2024-09-12+37,000→ 37,000 total
Award
TREVENA INC
Stock Option (Right to Buy)
2024-06-13+13,700→ 13,700 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-20+60,000→ 60,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-16+30,000→ 30,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-08-10+15,000→ 15,000 total
Award
TREVENA INC
Stock Option (Right to Buy)
2023-06-15+13,700→ 13,700 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-06-13+30,000→ 30,000 total
Award
TREVENA INC
Stock Option (Right to Buy)
2022-06-09+100,000→ 100,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2022-06-09+90,000→ 90,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2021-06-14+40,000→ 40,000 total
Award
TREVENA INC
Stock Option (Right to Buy)
2021-05-28+68,577→ 68,577 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2020-06-17+23,250→ 23,250 total
Award
TREVENA INC
Stock Option (Right to Buy)
2020-05-13+64,103→ 64,103 total
Disposition to Issuer
Dermira, Inc.
Restricted Stock Unit
2020-02-20−3,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−6,000→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−10,344→ 0 total
Disposition to Issuer
Dermira, Inc.
Director Stock Option (right to buy)
2020-02-20−10,334→ 0 total
Disposition to Issuer
Dermira, Inc.
Common Stock
2020-02-20$18.75/sh−6,000→ 0 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2019-10-10+46,500→ 46,500 total
Exercise/Conversion
Dermira, Inc.
Common Stock
2019-06-12−3,000→ 0 total
Exercise/Conversion
Dermira, Inc.
Common Stock
2019-06-12+3,000→ 6,000 total
Award
Dermira, Inc.
Restricted Stock Unit
2019-06-04+3,000→ 3,000 total
Award
Dermira, Inc.
Director Stock Option (right to buy)
2019-06-04+6,000→ 6,000 total
Award
TREVENA INC
Stock Option (Right to Buy)
2019-05-16+30,000→ 30,000 total
Exercise/Conversion
Dermira, Inc.
Restricted Stock Unit
2018-06-13−3,000→ 0 total

Companies

Recent Filings

Address

CHEMIN DES MINES 9

GENEVA, CH-1202

View on SEC.gov